Nu Skin Enterprises jumps on a deal to sell its Mavely marketing tech platform

Investing.com
01-03

Investing.com -- Shares of Nu Skin Enterprises Inc. jumped over 17% in pre-market trade on Friday after the company announced a transaction through its unit, Rhyz Inc., involving the sale of its Mavely affiliate marketing technology platform to Later, a portfolio company of Summit Partners. 

In exchange, Nu Skin received about $250 million, consisting of cash and a minority equity stake in the newly formed Later/Mavely business. About $33 million of the total is allocated for other equity holders in the Mavely venture.

This move is part of Nu Skin’s strategy to improve its position in the beauty, wellness, and lifestyle sectors. The integration of Later and Mavely is expected to strengthen the company’s affiliate marketing capabilities, with Mavely continuing to support Nu Skin’s operations.

Ryan Napierski, president and CEO of Nu Skin, stated that the transaction will help drive innovation within the company. 

The deal resulted in a five-times return on Nu Skin’s investment in Mavely since its acquisition in 2021. 

The proceeds will be used for debt reduction, investment in core operations, and stock repurchase. This will help improve Nu Skin’s financial position and provide value to shareholders.

Nu Skin worked with Evercore Group LLC as its financial advisor and Simpson Thacher&Bartlett LLP for legal counsel during the transaction.

The deal supports Nu Skin’s focus on its core business while allowing its units to grow through partnerships. 

The integration of Later and Mavely is expected to enhance the company’s capabilities and its commitment to growth and value creation.

Related Articles

Nu Skin Enterprises jumps on a deal to sell its Mavely marketing tech platform

US stocks higher; US Steel slumps after takeover barred

Airbus provisionally delivered over 765 jets in 2024, sources say

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10